Sumant Ramachandra
Patrimonio netto: 140 500 $ in data 30/06/2026
Patrimonio netto: 140 500 $ in data 30/06/2026
Attualmente, Sumant Ramachandra è Senior VP, Chief Science & Technology Officer di Baxter International, Inc. Il dott. Ramachandra è anche nel consiglio di amministrazione di Arog Pharmaceuticals, Inc. Ramachandra ha precedentemente ricoperto la posizione di Chief Scientific Officer & SVP-Regulatory Affairs presso Hospira, Inc., President-Research & Development presso Synta Pharmaceuticals Corp., Senior Vice President, Head-Research & Development presso Pfizer Essential Health e Vice President presso Schering-Plough Corp. Ha conseguito una laurea presso la Rutgers State University del New Jersey, un dottorato presso la University of Medicine & Dentistry of New Jersey e un MBA presso la Wharton School of the University of Pennsylvania.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 10/06/2026 | 10.000 ( 0,04% ) | 140 500 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Direttore/Membro del Consiglio | 01/11/2024 |
Arog Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatments | Direttore/Membro del Consiglio | - |
Lutris Pharma Ltd.
Lutris Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that improves anti cancer therapy effectiveness | Amministratore Delegato | 20/04/2025 |
| Società | Posizione | Fine |
|---|---|---|
Immpact Bio USA, Inc.
Immpact Bio USA, Inc. BiotechnologyHealth Technology Develops cell therapy for treating cancer | Amministratore Delegato | 31/10/2024 |
| BAXTER INTERNATIONAL INC. | Direttore Tecnico/Scientifico/R&S | 01/12/2021 |
| HOSPIRA, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2015 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Direttore Tecnico/Scientifico/R&S | 05/05/2013 |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Corporate Officer/Principal | 01/01/2008 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 12 |
|---|---|
Baxter International, Inc.
Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Hospira, Inc.
Hospira, Inc. Pharmaceuticals: MajorHealth Technology Provides drugs, IV sets and clinical integration & software, infusion pumps and implementation services | Health Technology |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Health Technology |
University of Medicine & Dentistry of New Jersey
University of Medicine & Dentistry of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arog Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatments | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer Essential Health
Pfizer Essential Health Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Lutris Pharma Ltd.
Lutris Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that improves anti cancer therapy effectiveness | Health Technology |
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
Immpact Bio USA, Inc.
Immpact Bio USA, Inc. BiotechnologyHealth Technology Develops cell therapy for treating cancer | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale